FIELD: medicine.
SUBSTANCE: substance of the invention consists in simulating acute mesenteric ischemia in rats followed by measuring the lymphocyte count in the central venous blood, and decreasing the measured count by more than 80% from average normal values enables diagnosing intestinal necrosis.
EFFECT: higher accuracy and simplifying the diagnosis of intestinal necrosis accompanying mesenteric ischemia.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING INTESTINAL NECROSIS IN PATIENTS WITH ACUTE MESENTERIC ISCHEMIA | 2018 |
|
RU2677652C1 |
| METHOD FOR DETERMINING TISSUE ISCHEMIA REVERSIBILITY | 2000 |
|
RU2162294C1 |
| METHOD FOR DETERMINING VIABILITY OF SMALL INTESTINE | 2018 |
|
RU2705940C1 |
| METHOD FOR PREDICTING ENTERAL INSUFFICIENCY IN PERITONITIS | 2022 |
|
RU2790193C1 |
| METHOD OF ASSESSING COMPLIANCE WITH A GLUTEN-FREE DIET IN PATIENTS WITH GLUTEN-SENSITIVE CELIAC DISEASE | 2022 |
|
RU2800820C1 |
| METHOD FOR DETECTING THE STAGES OF INTESTINAL FAILURE SYNDROME AT EXPERIMENTAL PERITONITIS | 2005 |
|
RU2294698C1 |
| METHOD FOR DIAGNOSING INTESTINAL VIABILITY AT MESENTERIC THROMBOSIS | 2002 |
|
RU2208380C1 |
| METHOD FOR SIMULATING OF ULCERATIVE COLITIS | 2015 |
|
RU2604044C1 |
| METHOD FOR TREATMENT OF ACUTE EXPERIMENTAL PANCREATITIS | 2001 |
|
RU2219948C2 |
| METHOD OF INVESTIGATING VIABILITY OF INTENSTINE IN CASE OF INTESTINAL OBSTRUCTION | 0 |
|
SU1421308A1 |
